REFERENCES
- Ortega, S.; Malumbres, M.; Barbacid, M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002, 1602(1), 73–87.
- Sgambato, A.; Cittadini, A.; Faraglia, B.; Weinstein, I.B. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. J Cell Physiol 2000, 183(1), 18–27.
- Blain, S.W.; Massagué, J. Breast cancer banishes p27 from nucleus. Nat Med 2002, 8(10), 1076–1078.
- Wu, Q.M.; Yu, J.P.; Tong, Q.; Wang, X.H.; Xie, G.J. Inhibition of adenovirus-mediated p27kip1 gene on growth of esophageal carcinoma cell strain. World J Gastroenterol 2003, 9(11), 2404–2408.
- Zhang, W.G.; Tong, Q.; Wu, Q.M.; Li, S.B.; Wang, X.H. Effect of p27kip1 gene transfer combined with chemotherapy on gastric carcinoma cells growth. Chin J Gastroenterol 2007, 12(10), 613–615.
- Zhang, W.; Tong, Q.; Li, S.; Wang, X.; Wang, Q. MG-132 inhibits telomerase activity, induces apoptosis and G(1) arrest associated with upregulated p27kip1 expression and downregulated survivin expression in gastric carcinoma cells. Cancer Invest 2008, 26(10), 1032–1036.
- Masciullo, V.; Susini, T.; Zamparelli, A.; Bovicelli, A.; Minimo, C.; Massi, D.; Taddei, G.; Maggiano, N.; De Iaco, P.; Ceccaroni, M.; Bovicelli, L.; Amunni, G.; Mancuso, S.; Scambia, G.; Giordano, A. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. Clin Cancer Res 2003, 9(14), 5332–5338.
- Polyak, K.; Kato, J.Y.; Solomon, M.J.; Sherr, C.J.; Massague, J.; Roberts, J.M.; Koff, A. p27kip1, a cyclin-CDK inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994, 8(1), 9–22.
- Abukhdeir, A.M.; Park, B.H. P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med 2008, 10, e19.
- Drexler, H.C.; Pebler, S. Inducible p27(Kip1) expression inhibits proliferation of K562 cells and protects against apoptosis induction by proteasome inhibitors. Cell Death Differ 2003, 10(3), 290–301.
- Shamma, A.; Doki, Y.; Tsujinaka, T.; Shiozaki, H.; Inoue, M.; Yano, M.; Kawanishi, K.; Monden, M. Loss of p27kip1 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncology 2000, 58 (2), 152–158.
- Galizia, G.; Ferraraccio, F.; Lieto, E.; Orditura, M.; Castellano, P.; Imperatore, V.; Romano, C.; Vollaro, M.; Agostini, B.; Pignatelli, C.; De Vita, F. Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery. Dis Colon Rectum 2004, 47(11), 1904–1914.
- Slingerland, J.; Pagano, M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000, 183(1), 10–17.
- Viglietto, G.; Motti, M.L.; Fusco, A. Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization. Cell Cycle 2002, 1(6), 394–400.
- Liang, J.; Zubovitz, J.; Petrocelli, T.; Kotchetkov, R.; Connor, M.K.; Han, K.; Lee, J.H.; Ciarallo, S.; Catzavelos, C.; Beniston, R.; Franssen, E.; Slingerland, J.M. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G_1 arrest. Nat Med 2002, 8(10), 1153–1160.
- Ambrosini, G.; Adida, C.; Altieri, D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997, 3(8), 917–921.
- Li, F.; Ambrosini, G.; Chu, E.Y.; Plescia, J.; Tognin, S.; Marchisio, P.C.; Altieri, D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998, 396(6711), 580–584.
- Blackburn, E. H. Structure and function of telomeres. Nature 1991, 350(6319), 569–573.
- Helder, M.N.; Wisman, G.B.; van der Zee, G.J. Telomerase and telomeres: from basic biology to cancer treatment. Cancer Invest 2002, 20(1), 82–101.